Abstract
Exploring current and future therapies for childhood astrocytoma Here, Doctor Peter J Houghton explains current therapies for childhood brain cancer what needs to change to ensure better outcomes for children diagnosed with astrocytoma in the future. Cancer in children is rare, representing less than 1% of all cancers in the U.S. Yet, despite major advances in treating childhood cancer, it remains the major cause of disease-related death in children up to 19 years of age in the U.S. It is estimated that 1 in 285 children will be diagnosed with cancer.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
